Patients with decompensated hepatitis B virus (HBV) cirrhosis have a poor prognosis due to the development of progressive liver failure and hepatocellular carcinoma. Lamivudine appears to be a ...
Sarcopenia is a common complication of decompensated cirrhosis resulting in progressive loss of muscle mass and function. The Food and Drug Administration (FDA) has granted Fast Track designation to ...
12d
Lipocine Inc. (LPCN), a biopharmaceutical company, Tuesday said that the U.S. Food and Drug Administration or FDA has granted Fast ...
Serious liver injury has been reported in patients with primary biliary cholangitis (PBC) without cirrhosis being treated ... due to reports of hepatic decompensation and failure among PBC ...
Background and Aim: The natural history of alcoholic cirrhosis, especially in Asian ... P = 0.0003), while the cumulative rates of hepatic decompensation (37.4% vs 51.7% at 10 years) and survival ...
LPCN 1148, an oral prodrug of bioidentical testosterone, was recently studied in a proof-of-concept (POC) Phase 2 study in patients with decompensated cirrhosis. Treatment with LPCN 1148 in the ...
According to National Institutes of Health, decompensated cirrhosis is an acute deterioration in liver function in a patient with cirrhosis. Fast Track Designation provides several benefits ...
LPCN 1148, an oral prodrug of bioidentical testosterone, was recently studied in a proof-of-concept (POC) phase 2 study in patients with decompensated cirrhosis. Treatment with LPCN 1148 in the POC ...
LPCN 1148, an oral prodrug of bioidentical testosterone, was recently studied in a proof-of-concept (POC) Phase 2 study in patients with decompensated cirrhosis. Treatment with LPCN 1148 in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback